COMUNICADO: Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capab

CAMBRIDGE, England, Jan. 6, 2020 /PRNewswire/ — Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the successful completion of the acquisition of Expedeon’s Proteomics and Immunology business, which includes Innova and TGR Biosciences, as of 1st January 2020. Abcam and Expedeon are fully committed to providing continued access to Expedeon’s proteomics and immunology products and support so that the life science community can perform their research and development without interruption.
Source: comunicados


Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

*
*

A %d blogueros les gusta esto: